Published in Heart Rhythm on November 02, 2010
Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv (2015) 1.49
The effects of LAA ligation on LAA electrical activity. Heart Rhythm (2014) 1.08
Epicardial interventions in electrophysiology. Circulation (2012) 1.00
Anticoagulation in atrial fibrillation. BMJ (2014) 0.93
Left atrial appendage closure to prevent stroke in patients with atrial fibrillation. Circulation (2014) 0.88
Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat Rev Cardiol (2013) 0.86
Intentional right atrial exit for microcatheter infusion of pericardial carbon dioxide or iodinated contrast to facilitate sub-xiphoid access. Catheter Cardiovasc Interv (2014) 0.82
A review of the LARIAT device: insights from the cumulative clinical experience. Springerplus (2015) 0.78
Left atrial appendage exclusion for stroke prevention in atrial fibrillation. Cardiol Res Pract (2012) 0.78
Left atrial appendage closure devices. Clin Med Insights Cardiol (2014) 0.78
Left atrial appendage as a target for reducing strokes: justifiable rationale? Safe and effective approaches? Heart Rhythm (2010) 0.77
Intentional Right Atrial Exit and Carbon Dioxide Insufflation to Facilitate Subxiphoid Needle Entry Into the Empty Pericardial Space: First Human Experience. JACC Clin Electrophysiol (2015) 0.77
Stroke prevention in nonvalvular atrial fibrillation. Tex Heart Inst J (2011) 0.77
Left Atrial Appendage Ligation and Exclusion Technology in the Incubator. J Atr Fibrillation (2015) 0.76
Safety and effectiveness of compassionate use of LARIAT® device for epicardial ligation of anatomically complex left atrial appendages. J Interv Card Electrophysiol (2015) 0.76
Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device. J Interv Card Electrophysiol (2015) 0.76
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials. Med Devices (Auckl) (2015) 0.76
Left atrial appendage exclusion for atrial fibrillation. Cardiol Clin (2014) 0.75
State Of The Art In Left Atrial Appendage Ligation - The Lariat. J Atr Fibrillation (2014) 0.75
Left atrial appendage occlusion procedures. Kardiochir Torakochirurgia Pol (2017) 0.75
Left Atrial Appendage Closure Devices For Stroke Prevention. Arrhythm Electrophysiol Rev (2014) 0.75
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol (2016) 0.75
A Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation. J Surg (Northborough) (2013) 0.75
Left Atrial Appendage Ligation And Exclusion Technology In The Incubator. J Atr Fibrillation (2015) 0.75
Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation. Tex Heart Inst J (2012) 0.75
Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target. Biomed Res Int (2015) 0.75
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility. Med Devices (Auckl) (2016) 0.75
Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation. Methodist Debakey Cardiovasc J (2015) 0.75
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88
Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation (2002) 3.71
Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol (2004) 3.44
Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol (2012) 3.12
Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol (1985) (2007) 2.52
Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol (2006) 2.48
Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol (2008) 2.44
Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng (2004) 2.42
Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00
Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm (2009) 2.00
Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol (2004) 1.91
Regional left atrial voltage in patients with atrial fibrillation. Heart Rhythm (2006) 1.84
Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm (2007) 1.82
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail (2012) 1.76
Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.72
Delayed perforation of the right ventricle as a complication of permanent cardiac pacing - is following the guidelines always the right choice? Non-standard treatment - a case report and literature review. Kardiol Pol (2010) 1.58
Postresuscitation stunning: postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload. J Cardiovasc Electrophysiol (2002) 1.48
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. Lancet (2002) 1.47
Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng (2006) 1.46
Effects of catheter ablation of idiopathic ventricular ectopic beats on left ventricular function and exercise capacity. Kardiol Pol (2009) 1.45
Surgical ablation for atrial fibrillation using the Ex-Maze III procedure on the beating heart in patients undergoing mitral valve surgery. Kardiol Pol (2011) 1.44
Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry. J Cardiovasc Electrophysiol (2010) 1.43
Predictors of axillary vein location for vascular access during pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol (2011) 1.42
Characteristics of the heart failure population in Poland: ZOPAN, a multicentre national programme. Kardiol Pol (2011) 1.42
Association between selected risk factors and the incidence of venous obstruction after pacemaker implantation: demographic and clinical factors. Kardiol Pol (2011) 1.41
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation (2003) 1.40
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation. Kardiol Pol (2011) 1.40
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. Eur Heart J (2005) 1.39
Clinical outcomes in patients after surgical and transcatheter aortic valve replacement. Pol Arch Med Wewn (2015) 1.39
The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol (2011) 1.39
Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. Pol Arch Med Wewn (2016) 1.39
[Atrio-ventricular block in the presence of double-chamber ICD--how is that possible?]. Kardiol Pol (2013) 1.39
Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease. Thromb Haemost (2012) 1.38
Shortening of paced QRS complex and clinical improvement following upgrading from apical right ventricular pacing to bifocal right ventricular or biventricular pacing in patients with permanent atrial fibrillation. Kardiol Pol (2010) 1.38
Bivalirudin in Acute Coronary Syndromes. N Engl J Med (2016) 1.37
The effects of radiofrequency ablation on left atrial systolic function in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardias. Kardiol Pol (2011) 1.37
Severe Accidental Hypothermia Center. Eur J Emerg Med (2015) 1.32
Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2009) 1.21
The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials (2010) 1.20
Increases in P-wave dispersion predict postoperative atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg (2004) 1.19
The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials (2008) 1.17
Atrial tachycardia arising from the coronary sinus musculature: electrophysiological characteristics and long-term outcomes of radiofrequency ablation. J Am Coll Cardiol (2005) 1.16
A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protoc (2006) 1.16
A first-degree family history in lone atrial fibrillation patients. Heart Rhythm (2008) 1.14
Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis. Eur J Cardiothorac Surg (2011) 1.12
Pinhole single-photon emission computed tomography for myocardial perfusion imaging of mice. J Am Coll Cardiol (2003) 1.12
Clinical expert consensus statement on best practices in the cardiac catheterization laboratory: Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2012) 1.11
Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model. Circ Cardiovasc Interv (2010) 1.11
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol (2009) 1.10
Impact of remote magnetic catheter navigation on ablation fluoroscopy and procedure time. Pacing Clin Electrophysiol (2008) 1.07
Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation (2002) 1.06
Repeat transseptal catheterization after ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.05
Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology (2006) 1.05
An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLoS One (2011) 1.05
Comparison of gene-transfer efficiency in human embryonic stem cells. Mol Imaging Biol (2009) 1.05
Heart perforation in patients with permanent cardiac pacing - pilot personal observations. Arch Med Sci (2012) 1.05
Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials (2005) 1.04
Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol (1985) (2008) 1.02
Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience. J Thorac Cardiovasc Surg (2010) 1.00
Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing Clin Electrophysiol (2008) 0.99
Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol (2013) 0.98
Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity. Int J Cardiol (2013) 0.98
The new face of bispecific antibodies: targeting cancer and much more. Exp Hematol (2006) 0.97
Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement. Eur Radiol (2005) 0.96
Surface electrocardiographic characteristics of right and left atrial flutter. Circulation (2003) 0.94
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation (2005) 0.93
Protracted CRP elevation after atrial fibrillation ablation. Pacing Clin Electrophysiol (2008) 0.93
Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med (2009) 0.93
Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail (2013) 0.92
Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis (2011) 0.92
Chemical and physical regulation of stem cells and progenitor cells: potential for cardiovascular tissue engineering. Tissue Eng (2007) 0.92
Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol (2008) 0.91
Engineering of aligned skeletal muscle by micropatterning. Am J Transl Res (2010) 0.91
Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol (2014) 0.89
Pleiotrophin induces formation of functional neovasculature in vivo. Biochem Biophys Res Commun (2005) 0.89
Protected circumferential conduction in the posterior atrioventricular vestibule of the left atrium: electrophysiologic and anatomic correlates. Pacing Clin Electrophysiol (2005) 0.89
Tissue engineering of muscle on micropatterned polymer films. Conf Proc IEEE Eng Med Biol Soc (2004) 0.89
Proteomic identification of biomarkers of vascular injury. Am J Transl Res (2010) 0.89
The relative importance of left atrial function versus dimension in predicting atrial fibrillation after coronary artery bypass graft surgery. Am Heart J (2002) 0.89
[POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities]. Kardiol Pol (2009) 0.88
Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease. J Thromb Thrombolysis (2013) 0.88
High-resolution optical mapping of ventricular tachycardia in rats with chronic myocardial infarction. Pacing Clin Electrophysiol (2010) 0.88
Transcatheter closure as an alternative and equivalent method to the surgical treatment of atrial septal defect in adults: comparison of early and late results. Med Sci Monit (2009) 0.88